Lung cancer, stomach cancer, hepatocellular cancer, pancreatic cancer, colorectal cancer, breast cancer
Conditions
Interventions
Experimental group:NK/NKT immunotherapy
Sponsors
Second People's Hospital of Shenzhen
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1) informed consent; 2) Age 18 to 70 years old; 3) pathological diagnosis of lung cancer, gastric cancer, hepatocellular carcinoma, pancreatic cancer, colorectal cancer, breast cancer; 4) Peripheral blood leukocytes> 3×10^9/L; Lymphocytes absolute> 1.0 × 10^9/L; Lymphocyte ratio> 18%; 5) survival expectation in more than 3 months.
Exclusion criteria
Exclusion criteria: 1) brain metastasis and macrovascular invasion; 2) highly allergic or have a history of serious allergies; 3) severe liver and kidney dysfunction; 4) patients with severe autoimmune disease or who are receiving immunosuppressive therapy; 5) serious infection uncontrolled or hyperthermia; 6) Organ transplant or organ transplant; 7) T-cell lymphoma, syphilis, AIDS patients or amalgamation; 8) shock, vital organ failure, unstable vital signs; 9) severe coagulation disorders (such as hemophilia) who; 10) the merger of mental or mental illness can not cooperate with the treatment and efficacy evaluation; 11) women of childbearing age during pregnancy or lactation, or women of childbearing age who refuse contraception during the study period; 12) drug or alcohol abusers; 13) The doctor thinks there are other reasons that can not be included in the treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tumor recurrence rate.;progression-free survival;overall survival; | — |
Countries
China
Contacts
Public ContactZeqiang Zhou
Department of oncology,Second People's Hospital of Shenzhen
Outcome results
None listed